Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19

Cited by (1,002)

Items 601–700 of 1,002

1. COVID-19 influenced gut dysbiosis, post-acute sequelae, immune regulation, and therapeutic regimens
   Sterlin Raj, Alexander W. Bruce, Muralidharan Anbalagan, Hemalatha Srinivasan, Sasikala Chinnappan, Mogana Sundari Rajagopal, Kushagra Khanna, Harish Chinna Konda Chandramoorthy, Ravishankar Ram Mani · 2024 · Frontiers in Cellular and Infection Microbiology
2. The Spectrum of Clinical and Serological Features of COVID-19 in Urban Hemodialysis Patients
   Teresa Stock da Cunha, Elena Gomá-Garcés, Alejandro Avello, Mónica Pereira, Sebastián Mas, Alberto Ortíz, Emilio González‐Parra · 2020 · Journal of Clinical Medicine
3. Immune Correlates of COVID-19 Control
   Bhawna Poonia, Shyam Kottilil · 2020 · Frontiers in Immunology
4. SIR economic epidemiological models with disease induced mortality
   Aditya Goenka, Lin Liu, Manh‐Hung Nguyen · 2021 · Journal of Mathematical Economics
5. Epitope similarity cannot explain the pre-formed T cell immunity towards structural SARS-CoV-2 proteins
   Ulrik Stervbo, Sven Rahmann, Toralf Roch, Timm Henning Westhoff, Nina Babel · 2020 · Scientific Reports
6. Rapid detection of SARS‐CoV‐2‐specific memory T‐cell immunity in recovered COVID‐19 cases
   Katie E. Lineburg, Sriganesh Srihari, Mohammed Altaf, Srividhya Swaminathan, Archana Panikkar, Jyothy Raju, Pauline Crooks, George R. Ambalathingal, José Paulo Martins, Katherine K. Matthews et al. · 2020 · Clinical & Translational Immunology
7. Immune profiling of COVID-19: preliminary findings and implications for the pandemic
   Holden Terry Maecker · 2021 · Journal for ImmunoTherapy of Cancer
8. Impaired Priming of SARS-CoV-2-Specific Naive CD8+ T Cells in Older Subjects
   Eleonora Gallerani, Davide Proietto, Beatrice Dallan, Marco Campagnaro, Salvatore Pacifico, Valentina Albanese, Erika Marzola, Peggy Marconi, Antonella Caputo, Victor Appay et al. · 2021 · Frontiers in Immunology
9. Determinants and Dynamics of SARS-CoV-2 Infection in a Diverse Population: 6-Month Evaluation of a Prospective Cohort Study
   Daniel B. Horton, Emily S. Barrett, Jason Roy, Maria Laura Gennaro, Tracy Andrews, Patricia J. Greenberg, Natalie Bruiners, Pratik Datta, Rahul Ukey, Senthil Kumar Velusamy et al. · 2021 · The Journal of Infectious Diseases
10. Levels of SARS-CoV-2 population exposure are considerably higher than suggested by seroprevalence surveys
    Siyu Chen, Jennifer A. Flegg, Lisa J. White, Ricardo J. Aguas · 2021 · PLoS Computational Biology
11. Postmortem high-dimensional immune profiling of severe COVID-19 patients reveals distinct patterns of immunosuppression and immunoactivation
    Haibo Wu, Peiqi He, Yong Ren, Shiqi Xiao, Wei Wang, Zhenbang Liu, Heng Li, Zhe Wang, Dingyu Zhang, Jun Cai et al. · 2022 · Nature Communications
12. Longevity of vaccine protection: Immunological mechanism, assessment methods, and improving strategy
    Zhian Chen, Xin Gao, Di Yu · 2022 · Open Research (University of Surrey)
13. The Spike Protein of SARS-CoV-2 Is Adapting Because of Selective Pressures
    Georgina I. López-Cortés, Miryam Palacios-Pérez, Hannya F. Veledíaz, Margarita M. Hernández-Aguilar, Gerardo R. López-Hernández, Gabriel S. Zamudio, Marco V. José · 2022 · Vaccines
14. Strong T-cell activation in response to COVID-19 vaccination in multiple sclerosis patients receiving B-cell depleting therapies
    Roberto Alfonso, Jerry Lin, Vanessa Kirschner, Joyce Lei, Grant Feuer, Michaela L. Malin, Jiayuan Liu, Morgan Roche, Saud Ahmed Sadiq · 2022 · Frontiers in Immunology
15. Allogeneic, off-the-shelf, SARS-CoV-2-specific T cells (ALVR109) for the treatment of COVID-19 in high-risk patients
    Spyridoula Vasileiou, LaQuisa Chimere Hill, Manik Kuvalekar, Aster G. Workineh, Ayumi Watanabe, Yovana Velazquez, Suhasini D. Lulla, Kimberly Mooney, Natalia Lapteva, Bambi Grilley et al. · 2022 · Haematologica
16. Safety and efficacy of COVID-19 prime-boost vaccinations: Homologous BBIBP-CorV versus heterologous BNT162b2 boosters in BBIBP-CorV-primed individuals
    Saad I. Mallah, Abdulla Ismaeel AlAwadhi, Jaleela Sayed Jawad, Pearl Wasif, Basma Alsaffar, Ejlal Alalawi, Afaf Mohamed, Alexandra E. Butler, Batool Alalawi, Donia Qayed et al. · 2023 · Vaccine
17. HLA-E–restricted SARS-CoV-2–specific T cells from convalescent COVID-19 patients suppress virus replication despite HLA class Ia down-regulation
    Hongbing Yang, Hong Sun, Simon Brackenridge, Xiaodong Alan Zhuang, Peter A. C. Wing, Max N. Quastel, Lucy C. Walters, Lee I. Garner, Beibei Wang, Xuan Yao et al. · 2023 · Science Immunology
18. DNA-launched RNA replicon vaccines induce potent anti-SARS-CoV-2 immune responses in mice
    I. Szurgot, L. Hanke, D. Sheward, L. P. Vidakovics, B. Murrell, G. Mcinerney, P. Liljeström · 2021 · Scientific Reports
19. The presence of serum anti‐SARS‐CoV‐2 IgA appears to protect primary health care workers from COVID‐19
    Viktoria Hennings, Karolina Thörn, Sofie Albinsson, Christine Lingblom, Kerstin Malm Andersson, Christer Andersson, Katarina Järbur, Rille Pullerits, Manja Idorn, Søren R. Paludan et al. · 2022 · European Journal of Immunology
20. Multi-antigen intranasal vaccine protects against challenge with sarbecoviruses and prevents transmission in hamsters
    Ankita Leekha, Arash Saeedi, K M Samiur Rahman Sefat, Monish Kumar, Melisa A. Martinez-Paniagua, Adrian Damian, Rohan SUDHIR Kulkarni, Kate Reichel, Ali Rezvan, Shalaleh Masoumi et al. · 2024 · Nature Communications
21. Systematic Examination of Antigen-Specific Recall T Cell Responses to SARS-CoV-2 versus Influenza Virus Reveals a Distinct Inflammatory Profile
    Jaclyn C. Law, Wan Hon Koh, Patrick Budylowski, Jonah Lin, F Yue, Kento T. Abe, Bhavisha Rathod, Mélanie Girard, Zhijie Li, James M. Rini et al. · 2020 · The Journal of Immunology
22. How Do Inflammatory Mediators, Immune Response and Air Pollution Contribute to COVID-19 Disease Severity? A Lesson to Learn
    Cinzia Signorini, Patrizia Pignatti, Teresa Coccini · 2021 · Life
23. Infection and Immune Memory: Variables in Robust Protection by Vaccines Against SARS-CoV-2
    Pankaj Kumar Ahluwalia, Kumar Vaibhav, Meenakshi Ahluwalia, Ashis Kumar Mondal, Nikhil Sahajpal, Amyn M. Rojiani, Ravindra B Kolhe · 2021 · Frontiers in Immunology
24. SARS-CoV-2-Specific Antibody and T Cell Response Kinetics According to Symptom Severity
    Ji Yeun Kim, Ji‐Soo Kwon, Seongman Bae, Hye Hee Cha, Joon Seo Lim, Min‐Chul Kim, Jin-Won Chung, Se Yoon Park, Myung Jin Lee, Baek-Nam Kim et al. · 2021 · American Journal of Tropical Medicine and Hygiene
25. Recombinant chimpanzee adenovirus AdC7 expressing dimeric tandem-repeat spike protein RBD protects mice against COVID-19
    Kun Xu, Yaling An, Qunlong Li, Wei-Jing Huang, Yuxuan Han, Tianyi Zheng, Fang Fang, Hui Liu, Chuan-Yu Liu, Ping Gao et al. · 2021 · Emerging Microbes and Infections
26. Immunopathology and Immunosenescence, the Immunological Key Words of Severe COVID-19. Is There a Role for Stem Cell Transplantation?
    Mattia Emanuela Ligotti, Fanny Pojero, Giulia Accardi, Anna Aiello, Calogero Caruso, Giovanni Duro, Giuseppina Candore · 2021 · Frontiers in Cell and Developmental Biology
27. Immunoinformatics mapping of potential epitopes in SARS-CoV-2 structural proteins
    Yengkhom Damayanti Devi, Himanshu Ballav Goswami, Sushmita Konwar, Chandrima Doley, Anutee Dolley, Arpita Devi, Chen Chongtham, Dikshita Dowerah, Vashkar Biswa, Latonglila Jamir et al. · 2021 · PLoS ONE
28. Rapid test to assess the escape of SARS-CoV-2 variants of concern
    Jacob T. Heggestad, Rhett J. Britton, David Kinnamon, Simone A. Wall, Daniel Y. Joh, Angus Hucknall, Lyra B. Olson, Jack G. Anderson, Anna Mazur, Cameron R. Wolfe et al. · 2021 · Science Advances
29. ABO blood group is involved in the quality of the specific immune response anti-SARS-CoV-2
    Sergio Gil-Manso, Iria Miguéns Blanco, Bruce Motyka, Anne Halpin, Rocío López-Esteban, Verónica Astrid Pérez-Fernández, Diego Carbonell, Luis Andrés López-Fernández, Lori J. West, Rafael Correa‐Rocha et al. · 2021 · Virulence
30. Molecular and Clinical Prognostic Biomarkers of COVID-19 Severity and Persistence
    Gethsimani Papadopoulou, Eleni Manoloudi, Nikolena Repousi, Lemonia Skoura, Tara Patricia Hurst, Timokratis Karamitros · 2022 · Pathogens
31. Pre-existing T Cell Memory against Zika Virus
    Blake Schouest, Alba Grifoni, John W. Pham, José Mateus, John Sydney, James D. Brien, Aruna Dharshan De Silva, Ángel Balmaseda, Eva Harris, Alessandro Sette et al. · 2021 · Journal of Virology
32. Scientists have favorable opinions on immunity certificates but raise concerns regarding fairness and inequality
    Iván Aranzales, Ho Fai Chan, Reiner Eichenberger, Rainer Hegselmann, David Stadelmann, Benno Torgler · 2021 · Scientific Reports
33. COVID-19 pandemic: the delta variant, T-cell responses, and the efficacy of developing vaccines
    B. Biswas, Shagnik Chattopadhyay, Sayantee Hazra, Arman Kunwar Hansda, R. Goswami · 2022 · Inflammation Research
34. Low rate of COVID-19 seroconversion in health-care workers at a Department of Infectious Diseases in Sweden during the later phase of the first wave; a prospective longitudinal seroepidemiological study
    Mulki Rashid Teljebäck, Anders Krifors, Andreas Sälléber, Jenny Eriksson, Emeli Månsson · 2020 · Scandinavian Journal of Infectious Diseases
35. Longitudinal Assessment of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Immune Responses for Six Months Based on the Clinical Severity of Coronavirus Disease 2019
    Ji Yun Noh, Jeong-Eun Kwak, Jeong‐Sun Yang, Soon Young Hwang, Jin Gu Yoon, Hye Seong, Hakjun Hyun, Chae Seung Lim, Soo‐Young Yoon, Jungsang Ryou et al. · 2021 · The Journal of Infectious Diseases
36. Genetic Evidence and Host Immune Response in Persons Reinfected with SARS-CoV-2, Brazil
    Natalia Fintelman Rodrigues, Aline de Paula Dias da Silva, Monique Cristina dos Santos, Felipe Saraiva, Marcelo Alves Ferreira, João Silveira Moledo Gesto, Danielle A. S. Rodrigues, Andre Macedo Vale, Isaclaudia Gomes de Azevedo, Vinícius Cardoso Soares et al. · 2021 · Emerging infectious diseases
37. Dual-Antigen COVID-19 Vaccine Subcutaneous Prime Delivery With Oral Boosts Protects NHP Against SARS-CoV-2 Challenge
    Elizabeth Gabitzsch, Jeffrey T. Safrit, Mohit S. Verma, Adrian Rice, Peter A. Sieling, Lise Zakin, Annie Shin, Brett Morimoto, Helty Adisetiyo, Raymond M.H. Wong et al. · 2021 · Frontiers in Immunology
38. SARS‐CoV‐2 memory B and T cell profiles in mild COVID‐19 convalescent patients
    Michael Gurevich, Rina Zilkha‐Falb, Polina Sonis, David Magalashvili, Shay Menascu, Shlomo Flechter, Mark Dolev, Mathilda Mandel, Anat Achiron · 2021 · International Journal of Infectious Diseases
39. Cellular and Humoral Immunity to SARS‐CoV‐2 Infection in Multiple Sclerosis Patients on Ocrelizumab and Other Disease‐Modifying Therapies: A Multi‐Ethnic Observational Study
    Ilya Kister, Y. Patskovsky, Ryan Curtin, Jinglan Pei, Katherine Perdomo, Zoe Rimler, Iryna Voloshyna, Marie I. Samanovic, Amber R. Cornelius, Yogambigai Velmurugu et al. · 2022 · Annals of Neurology
40. Inducing broad-based immunity against viruses with pandemic potential
    Alessandro Sette, Erica Ollmann Saphire · 2022 · Immunity
41. Parallel detection of SARS‐CoV ‐2 epitopes reveals dynamic immunodominance profiles of CD8 + T memory cells in convalescent COVID ‐19 donors
    Jet van den Dijssel, Ruth R. Hagen, Rivka de Jongh, Maurice Steenhuis, Theo Rispens, Dionne M. Geerdes, Juk Yee Mok, Angela HM. Kragten, Mariël C Duurland, Niels J. M. Verstegen et al. · 2022 · Clinical & Translational Immunology
42. SARS‐CoV‐2 nucleocapsid: Biological functions and implication for disease diagnosis and vaccine design
    Faezeh Maghsood, Ahmad Ghorbani Vanan, Hamidreza Yadegari, Forough Golsaz‐Shirazi, Mohammad Mehdi Amiri, Fazel Shokri · 2023 · Reviews in Medical Virology
43. Prevalence and functional profile of SARS-CoV-2 T cells in asymptomatic Kenyan adults
    Taraz Samandari, Joshua Ongalo, Kimberly D. McCarthy, Richard Biegon, Philister Adhiambo Madiega, Anne Mithika, Joseph Orinda, Grace Mboya, Patrick Mwaura, Omu Aggrey Anzala et al. · 2023 · Journal of Clinical Investigation
44. Extracellular vesicle-based vaccine platform displaying native viral envelope proteins elicits a robust anti-SARS-CoV-2 response in mice
    Katarzyna Polak, N. Greze, Maëlle Lachat, Delphine Merle, Steve Chiumento, Christelle Bertrand‐Gaday, Bernadette Trentin, Robert Z. Mamoun · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
45. SARS-CoV-2 spike-specific nasal-resident CD49a+CD8+ memory T cells exert immediate effector functions with enhanced IFN-γ production
    Min‐Seok Rha, Gyeongyeob Kim, Sol Lee, Jihye Kim, Yeonsu Jeong, Chan Min Jung, Hae Eun Noh, Ji Yun Noh, Yong Min Kim, Hyung‐Ju Cho et al. · 2024 · Nature Communications
46. Prolonged adaptive immune activation in COVID-19: implications for maintenance of long-term immunity?
    Philip A. Mudd, Kenneth E. Remy · 2020 · Journal of Clinical Investigation
47. Chilblain‐like lesions and COVID‐19: second wave, second outbreak
    Vincenzo Piccolo, Andrea Bassi, Teresa Palmira Russo, Carlo Mazzatenta, M. Baraldi, Giuseppe Argenziano, Iria Neri, Mario Cutrone · 2021 · Journal of the European Academy of Dermatology and Venereology
48. Immunosuppression as a Hallmark of Critical COVID-19: Prospective Study
    Elżbieta Kalicińska, Donata Szymczak, Aleksander Zińczuk, Barbara Adamik, Jakub Śmiechowicz, Tomasz Skalec, Danuta Nowicka‐Suszko, Monika Biernat, Aleksandra Bogucka‐Fedorczuk, Justyna Rybka et al. · 2021 · Cells
49. Cellular Immune Response after Vaccination in Patients with Cancer—Review on Past and Present Experiences
    Maria Madeleine Rüthrich, Nicola Giesen, Sibylle C. Mellinghoff, Christina Theresa Rieger, Marie von Lilienfeld‐Toal · 2022 · Vaccines
50. SARS-CoV-2 T Cell Response in Severe and Fatal COVID-19 in Primary Antibody Deficiency Patients Without Specific Humoral Immunity
    Sophie Steiner, Tatjana Schwarz, Victor M. Corman, Laura Gebert, Malte C. Kleinschmidt, Alexandra Wald, Sven Gläser, Jan Matthias Kruse, Daniel Zickler, Alexander Peric et al. · 2022 · Frontiers in Immunology
51. Oral subunit SARS-CoV-2 vaccine induces systemic neutralizing IgG, IgA and cellular immune responses and can boost neutralizing antibody responses primed by an injected vaccine
    Jacob Pitcovski, Nady Gruzdev, Anna Abzach, Chen Katz, Ran Ben‐Adiva, Michal Brand Shwartz, Itamar Yadid, Einav Ratzon-Ashkenazi, Ken Emquies, Hadasa Israeli et al. · 2022 · Vaccine
52. Mouse models in COVID-19 research: analyzing the adaptive immune response
    S. Clever, A. Volz · 2022 · Medical Microbiology and Immmunology
53. Omicron BA.1 Mutations in SARS-CoV-2 Spike Lead to Reduced T-Cell Response in Vaccinated and Convalescent Individuals
    Maarten E. Emmelot, Martijn W. Vos, Mardi C. Boer, Nynke Y. Rots, Jelle de Wit, Cécile A. C. M. van Els, Patricia Kaaijk · 2022 · Viruses
54. Current understanding of T cell immunity against SARS-CoV-2
    Xiuyuan Lu, Sho Yamasaki · 2022 · Inflammation and Regeneration
55. Impact of Prior COVID-19 Immunization and/or Prior Infection on Immune Responses and Clinical Outcomes
    Achilleas Livieratos, Charalambos A. Gogos, Karolina Akinosoglou · 2024 · Viruses
56. A Systems Biology Workflow for Drug and Vaccine Repurposing: Identifying Small-Molecule BCG Mimics to Reduce or Prevent COVID-19 Mortality
    Rima Hajjo, Alexander Tropsha · 2020 · Pharmaceutical Research
57. Maturation of T and B Lymphocytes in the Assessment of the Immune Status in COVID-19 Patients
    Iwona Kwiecień, Elżbieta Rutkowska, Krzysztof Kłos, Ewa Więsik–Szewczyk, Karina Jahnz‐Różyk, Piotr Rzepecki, Andrzej Chciałowski · 2020 · Cells
58. Heterogeneous magnitude of immunological memory to SARS‐CoV‐2 in recovered individuals
    Alessio Mazzoni, Laura Maggi, Manuela Capone, Anna Vanni, Michele Spinicci, Lorenzo Salvati, Seble Tekle Kiros, Roberto Semeraro, Luca Pengue, Maria Grazia Colao et al. · 2021 · Clinical & Translational Immunology
59. Highly feasible immunoprotective multicistronic SARS-CoV-2 vaccine candidate blending novel eukaryotic expression and Salmonella bactofection
    Vijayakumar Jawalagatti, Perumalraja Kirthika, Ji-Young Park, Chamith Hewawaduge, John Hwa Lee · 2021 · Journal of Advanced Research
60. T Cells Targeting SARS-CoV-2: By Infection, Vaccination, and Against Future Variants
    Thi H. O. Nguyen, Carolyn A. Cohen, Louise C. Rowntree, Maireid B. Bull, Asmaa Hachim, Katherine Kedzierska, Sophie A. Valkenburg · 2021 · Frontiers in Medicine
61. VITT after ChAdOx1 nCoV-19 Vaccination
    Christian Weber, Philipp von Hundelshausen, Wolfgang Siess · 2021 · New England Journal of Medicine
62. Hybrid Immunity against SARS-CoV-2 Variants: A Narrative Review of the Literature
    Panagiota Tsagkli, Maria Geropeppa, Ioanna Papadatou, Vana I. Spoulou · 2024 · Vaccines
63. SARS-CoV-2: The Interplay Between Evolution and Host Immunity
    James Brett Case, Shilpi Jain, Mehul S. Suthar, Michael Diamond · 2024 · Annual Review of Immunology
64. Antibodies at work in the time of severe acute respiratory syndrome coronavirus 2
    Kuttuvan Valappil Sajna, Siya Kamat · 2020 · Cytotherapy
65. Biomaterials-Based Opportunities to Engineer the Pulmonary Host Immune Response in COVID-19
    Bader M. Jarai, Zachary S. Stillman, Kartik Bomb, April M. Kloxin, Catherine A. Fromen · 2020 · ACS Biomaterials Science & Engineering
66. Polymeric Pathogen-Like Particles-Based Combination Adjuvants Elicit Potent Mucosal T Cell Immunity to Influenza A Virus
    Brock A. Kingstad-Bakke, Randall Toy, Woo‐Jong Lee, Pallab Pradhan, Gabriela Vogel, Chandranaik Basavegowdanadoddi Marinaik, Autumn Larsen, Daisy E. Gates, Tracy Luu, Bhawana Pandey et al. · 2021 · Frontiers in Immunology
67. The importance of genomic analysis in cracking the coronavirus pandemic
    Davide Zella, Marta Giovanetti, Eleonora Cella, Alessândra Borsetti, Marco Ciotti, Giancarlo Ceccarelli, Gabriella d’Ettorre, Aldo Pezzuto, Vittoradolfo Tambone, Laura Leondina Campanozzi et al. · 2021 · Expert Review of Molecular Diagnostics
68. Determinants of IgG antibodies kinetics after severe and critical COVID‐19
    Julien De Greef, Anaïs Scohy, Francis Zech, Frank Aboubakar Nana, Charles Pilette, Ludovic Gérard, Lucie Pothen, Halil Yıldız, Leïla Belkhir, Jean Cyr Yombi · 2021 · Journal of Medical Virology
69. Epidemiological feature, viral shedding, and antibody seroconversion among asymptomatic SARS-CoV-2 carriers and symptomatic/presymptomatic COVID-19 patients
    Yi Chen, Ping Li, Yibo Ding, Miao Liu, Leijie Liu, Bo Yi, Ting Wu, Hongjun Dong, Xuying Lao, Keqing Ding et al. · 2021 · Journal of Infection and Public Health
70. Critical COVID‐19 is associated with distinct leukocyte phenotypes and transcriptome patterns
    Erik Egeland Christensen, Marthe Jøntvedt Jørgensen, Kristin Grotle Nore, Tuva Børresdatter Dahl, Kuan Yang, Trine Ranheim, Camilla Huse, Andreas Lind, Sarah Nur, Birgitte Stiksrud et al. · 2021 · Journal of Internal Medicine
71. T cell–mediated response to SARS-CoV-2 in liver transplant recipients with prior COVID-19
    Mario Fernández‐Ruiz, Beatriz Olea, Patricia Almendro-Vázquez, Estela Giménez, Alberto Marcacuzco, Rafael San Juan, Iago Justo, Jorge Calvo, Álvaro García‐Sesma, Alejandro Manrique et al. · 2021 · American Journal of Transplantation
72. IFN‐γ+ cell response and IFN‐γ release concordance after in vitro SARS‐CoV‐2 stimulation
    Alejandro Vallejo, Pilar Vizcarra, Carmen Quereda, Ana Maria Moreno, José L. Casado, the CoVEX study group · 2021 · European Journal of Clinical Investigation
73. The Evolution of Single-Cell Analysis and Utility in Drug Development
    Shibani Mitra‐Kaushik, Anita Mehta-Damani, Jennifer J. Stewart, Cherie Green, Virginia Litwin, Christèle Gonneau · 2021 · The AAPS Journal
74. IL-17A–producing sinonasal MAIT cells in patients with chronic rhinosinusitis with nasal polyps
    Min‐Seok Rha, Young Hoon Yoon, June‐Young Koh, Jae Hyung Jung, Ha Seok Lee, Soo Kyoung Park, Su‐Hyung Park, Yong Min Kim, Ki‐Sang Rha, Eui‐Cheol Shin · 2021 · Journal of Allergy and Clinical Immunology
75. Possible harm from glucocorticoid drugs misuse in the early phase of SARS-CoV-2 infection: a narrative review of the evidence
    Riccardo Sarzani, Francesco Spannella, Federico Giulietti, Chiara Di Pentima, Piero Giordano, Andrea Giacometti · 2021 · Internal and Emergency Medicine
76. Immune interventions in COVID-19: a matter of time?
    Léo Plaçais, Quentin Richier, Nicolas Noël, Karine Lacombe, Xavier Mariette, Olivier Hermine · 2021 · Mucosal Immunology
77. Humoral and Cellular Responses to SARS-CoV-2 in Convalescent COVID-19 Patients With Multiple Sclerosis
    Ana Zabalza, Georgina Arrambide, Paula Tagliani, Simón Cárdenas‐Robledo, Susana Otero‐Romero, Juliana Esperalba, Candela Fernández‐Naval, Jesus Trocoli Campuzano, Mónica Martínez‐Gallo, Mireia Castillo et al. · 2022 · Neurology Neuroimmunology & Neuroinflammation
78. HLA‐dependent variation in SARS‐CoV‐2 CD8 + T cell cross‐reactivity with human coronaviruses
    Paul R. Buckley, Chloe Hyun-Jung Lee, Mariana Pereira Pinho, Rosana Ottakandathil Babu, Jeongmin Woo, Agne Antanaviciute, Alison Simmons, Graham Stuart Ogg, Hashem Koohy · 2022 · Immunology
79. T‐cell responses to SARS‐CoV‐2 Omicron spike epitopes with mutations after the third booster dose of an inactivated vaccine
    Yongzheng Li, Xiuwen Wang, Junyan Jin, Zhenglai Ma, Yan Liu, Xin Zhang, Bin Su · 2022 · Journal of Medical Virology
80. SARS-CoV-2 vaccination diversifies the CD4+ spike-reactive T cell repertoire in patients with prior SARS-CoV-2 infection
    Arbor G. Dykema, Boyang Zhang, Bezawit A. Woldemeskel, Caroline C. Garliss, Rufiaat Rashid, Timothy Westlake, Li Zhang, Jiajia Zhang, Laurene S. Cheung, Justina X. Caushi et al. · 2022 · EBioMedicine
81. SARS-CoV-2 immunity and vaccine strategies in people with HIV
    Claire Mullender, Kelly da Costa, Aljawharah Alrubayyi, Sarah Lilian Pett, Dimitra Peppa · 2022 · Oxford Open Immunology
82. Accumulation of mutations in antibody and CD8 T cell epitopes in a B cell depleted lymphoma patient with chronic SARS-CoV-2 infection
    Elham Khatamzas, Markus H. Antwerpen, Alexandra Rehn, Alexander Graf, Johannes C. Hellmuth, Alexandra Hollaus, Anne‐Wiebe Mohr, Erik Gaitzsch, Tobias Weiglein, Enrico Georgi et al. · 2022 · Nature Communications
83. Protection from COVID-19 with a VSV-based vaccine expressing the spike and nucleocapsid proteins
    Kyle Lee O’Donnell, Tylisha Gourdine, Paige Fletcher, Chad S. Clancy, Andrea Marzi · 2022 · Frontiers in Immunology
84. Emerging Effects of IL-33 on COVID-19
    Yuan Gao, Luwei Cai, Lili Li, Yidan Zhang, Jing Li, Chengliang Luo, Ying Wang, Luyang Tao · 2022 · International Journal of Molecular Sciences
85. Respiratory mucosal vaccination of peptide-poloxamine-DNA nanoparticles provides complete protection against lethal SARS-CoV-2 challenge
    Si Sun, Entao Li, Gan Zhao, Jie Tang, Qianfei Zuo, Larry Cai, Chuanfei Xu, Cheng Sui, Yangxue Ou, Chang Liu et al. · 2022 · Biomaterials
86. Structural insights into protection against a SARS-CoV-2 spike variant by T cell receptor diversity
    Daichao Wu, Grigory Aleksandrovich Efimov, Боголюбова Аполлинария Васильевна, Brian G. Pierce, Roy A. Mariuzza · 2023 · Journal of Biological Chemistry
87. SARS-CoV-2 epitope-specific T cells: Immunity response feature, TCR repertoire characteristics and cross-reactivity
    Gang Yang, Junxiang Wang, Ping Sun, Jian Qin, Xiaoyun Yang, Daxiang Chen, Yunhui Zhang, Nanshan S Zhong, Zhongfang Wang · 2023 · Frontiers in Immunology
88. The Potential of Probiotics as Ingestible Adjuvants and Immune Modulators for Antiviral Immunity and Management of SARS-CoV-2 Infection and COVID-19
    Sophie Tomkinson, Cloe Triscott, Emily Schenk, Andrew Foey · 2023 · Pathogens
89. CD4 + and CD8 + T cells are required to prevent SARS-CoV-2 persistence in the nasal compartment
    Meenakshi Kar, Katherine Johnson, Abigail Vanderheiden, Elizabeth J. Elrod, Katharine A. Floyd, Elizabeth Geerling, E. Taylor Stone, Eduardo Salinas, Stephanie Banakis, Wei Wang et al. · 2024 · Science Advances
90. Single-cell sequencing reveals cellular landscape alterations in the airway mucosa of patients with pulmonary long COVID
    Firoozeh V. Gerayeli, Hye Yun Park, Stephen B Milne, Xuan Li, Chen Xi Yang, Josie Tuong, Rachel L. Eddy, Seyed Milad Vahedi, Elizabeth Guinto, Chung Yan Cheung et al. · 2024 · European Respiratory Journal
91. Longitudinal analysis of antibody response following SARS-CoV-2 infection in pregnancy: From the first trimester to delivery
    Stefano Domenico Cosma, Andrea Roberto Carosso, Silvia Corcione, Jessica Cusato, Fulvio Borella, Miriam Antonucci, Luca Marozio, Alberto Revelli, Mario Preti, Valeria Ghisetti et al. · 2021 · Journal of Reproductive Immunology
92. Immunity after SARS-CoV-2 infections
    Prasanna Jagannathan, Taia T. Wang · 2021 · Nature Immunology
93. Impaired Humoral Immunity to SARS-CoV-2 Vaccination in Non-Hodgkin Lymphoma and CLL Patients
    Catherine Diefenbach, Jessica Caro, Akiko Koide, Michael L. Grossbard, Judith D. Goldberg, Bruce G. Raphael, Kenneth B. Hymes, Tibor Moskovits, Maxim Kreditor, David Kaminetzky et al. · 2021 · medRxiv
94. Large libraries of single-chain trimer peptide-MHCs enable antigen-specific CD8+ T cell discovery and analysis
    William Chour, Jongchan Choi, Jingyi Xie, Mary E. Chaffee, Thomas M. Schmitt, Kathryn A. K. Finton, Diana C. DeLucia, Alexander M. Xu, Yapeng Su, Daniel G. Chen et al. · 2023 · Communications Biology
95. T-Cell Immune Responses to SARS-CoV-2 Infection and Vaccination
    Samuele Notarbartolo · 2024 · Vaccines
96. A Dual-Antigen Enzyme-Linked Immunosorbent Assay Allows the Assessment of Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Seroprevalence in a Low-Transmission Setting
    Sarah M. Hicks, Kai G. Pohl, Teresa M. Neeman, Hayley A. McNamara, Kate M. Parsons, Jin-Shu He, Sidra Asad Ali, Samina Nazir, Louise C. Rowntree, Thi H. O. Nguyen et al. · 2020 · The Journal of Infectious Diseases
97. Reinfection, recurrence, or delayed presentation of COVID-19? Case series and review of the literature
    F. Elzein, A. Ibrahim, F. Alshahrani, M. Mahrous, E. Murshid, Turki Aldhehyan, Ghadah Almutiri, Meshal Altowairqi, Medina A. Ahmed, Mohammed Alsaeed et al. · 2021 · Journal of Infection and Public Health
98. A Novel DNA Vaccine Against SARS-CoV-2 Encoding a Chimeric Protein of Its Receptor-Binding Domain (RBD) Fused to the Amino-Terminal Region of Hepatitis B Virus preS1 With a W4P Mutation
    Hyein Jeong, Yu-Min Choi, Hyejun Seo, Bum‐Joon Kim · 2021 · Frontiers in Immunology
99. Long-Term Elevated Inflammatory Protein Levels in Asymptomatic SARS-CoV-2 Infected Individuals
    Liina Tserel, Piia Jõgi, Paul Naaber, Julia Maslovskaja, Annika Häling, Ahto Salumets, Eva Žusinaite, Hiie Soeorg, Freddy Lättekivi, Diana Ingerainen et al. · 2021 · Frontiers in Immunology
100. Persistence of T Cell and Antibody Responses to SARS-CoV-2 Up to 9 Months after Symptom Onset
     Jaclyn C. Law, Mélanie Girard, Gary Y. C. Chao, Lesley A. Ward, Baweleta Isho, Bhavisha Rathod, Karen Colwill, Zhijie Li, James M. Rini, Feng Yun Yue et al. · 2021 · The Journal of Immunology